Status:
RECRUITING
Magnesium Sulfate in Addition to Bupivacaine in Ultrasound-guided Transmuscular Quadratus Lumborum Block for Post-Operative Analgesia After Total Hip Arthroplasty
Lead Sponsor:
Tanta University
Conditions:
Pain Score Reduction
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
The aim of this clinical trial is to evaluate the efficacy of adding magnesium sulfate to bupivacaine in ultrasound-guided transmuscular quadratus lumborum block for postoperative analgesia in adult p...
Detailed Description
The quadratus lumborum block (QLB) is an abdominal wall fascial block plane block described for providing perioperative analgesia for abdominal, hip and lower limb surgeries . Opioid-sparing analgesic...
Eligibility Criteria
Inclusion
- Age ≥ 18 years.
- American Society of Anesthesiology (ASA) class I-III
- Undergoing hip arthroplasty .
Exclusion
- Patient refusal.
- Body mass index (BMI) \> 40 Kg/m2.
- Allergy to local anesthetics or magnesium sulphate.
- coexisting coagulopathy.
- Local infection at puncture site.
- Severe renal impairment ( eGFR \< 30 ml/min)
Key Trial Info
Start Date :
May 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2025
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06956950
Start Date
May 1 2025
End Date
November 1 2025
Last Update
May 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of medicine
Tanta, El-Gharbia, Egypt, 31527